Cartalax
Also known as: Ala-Glu-Asp
Cartalax is a synthetic tripeptide (Ala-Glu-Asp / AED) from the Khavinson bioregulator series, studied in Russian preclinical models on fibroblast and chondrocyte cultures. Not FDA-approved; no Western clinical trials exist, and all published evidence originates from a single research group.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Cartalax
16 third-party tests across 5 vendors. Each card links to the full report.
For
Cartalax
by Verified Peptides· batch 09-25-030C
For
Cartalax
by BioLongevity Labs· batch 35-3-46057
For
Cartalax
by Mile High Compounds· batch CAR-025-MH-01
For
Cartalax
by BioLongevity Labs· batch A
For
Cartalax
by BioLongevity Labs· batch 251617
For
Cartalax
by Skye Peptides· batch CTX25-25-002
For
Cartalax
by BioLongevity Labs· batch 35-1-45834
For
Cartalax
by BioLongevity Labs· batch QC251142
For
Cartalax
by Verified Peptides· batch 01-25-0510F
For
Cartalax
by Glacier Aminos· batch CLX20GA01
Purity not on file
For
Cartalax
by Verified Peptides· batch 09-25-030C
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 35-3-45958
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 251617
Purity not on file
For
Cartalax
by Skye Peptides· batch CTX25-25-002
Purity not on file
For
Cartalax
by Skye Peptides· batch CTX25-25-002
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 36-3-45777